Gilead Sciences, Inc.GILDNASDAQ
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank26
Year-over-Year Change
Year-over-year net income growth rate
Percentile
P26
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -28.47% |
| Q3 2025 | 55.71% |
| Q2 2025 | 49.05% |
| Q1 2025 | -26.25% |
| Q4 2024 | 42.30% |
| Q3 2024 | -22.37% |
| Q2 2024 | 138.71% |
| Q1 2024 | -391.81% |
| Q4 2023 | -34.45% |
| Q3 2023 | 108.61% |
| Q2 2023 | 3.47% |
| Q1 2023 | -38.41% |
| Q4 2022 | -8.33% |
| Q3 2022 | 56.38% |
| Q2 2022 | 5921.05% |
| Q1 2022 | -95.03% |
| Q4 2021 | -85.26% |
| Q3 2021 | 70.30% |
| Q2 2021 | -11.97% |
| Q1 2021 | 11.48% |
| Q4 2020 | 330.83% |
| Q3 2020 | 110.78% |
| Q2 2020 | -315.28% |
| Q1 2020 | -42.47% |
| Q4 2019 | 331.42% |
| Q3 2019 | -161.97% |
| Q2 2019 | -4.81% |
| Q1 2019 | 65733.33% |
| Q4 2018 | -99.86% |
| Q3 2018 | 15.41% |
| Q2 2018 | 18.14% |
| Q1 2018 | 139.79% |
| Q4 2017 | -242.20% |
| Q3 2017 | -11.55% |
| Q2 2017 | 13.73% |
| Q1 2017 | -13.06% |
| Q4 2016 | -6.67% |
| Q3 2016 | -4.78% |
| Q2 2016 | -1.93% |
| Q1 2016 | -23.85% |